Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. L'Oréal
  6. News
  7. Summary
    OR   FR0000120321

L'ORÉAL

(OR)
  Report
Real-time Quote. Real-time Euronext Paris - 01/19 09:05:27 am
379.05 EUR   +0.81%
01/18LOREAL : UBS reiterates its Buy rating
MD
01/18LOREAL : Gets a Buy rating from JP Morgan
MD
01/17LOREAL : JP Morgan keeps its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

L'Oréal and Symatese strengthen their strategic research partnership on biomaterials

10/28/2021 | 01:33pm EST

NEWS

RELEASE

L'ORÉAL AND SYMATESE STRENGTHEN THEIR STRATEGIC RESEARCH PARTNERSHIP

ON BIOMATERIALS

Clichy / Lyon, 28 October 2021 - L'Oréal and Symatese have announced the signing of new long-term research and development agreements in the field of biomaterials, to strengthen and broaden their existing strategic partnership. Together, the companies aspire to combine their respective expertise to explore new scientific perspectives in the field of biomaterials designed for the physiology of human tissues including skin, notably for regeneration purposes.

This research partnership builds on the success of the close collaboration between the two companies during the past 20 years. Episkin S.A., a subsidiary of the L'Oréal group, the world leader in the production of reconstructed human tissues, has benefitted from the know-how developed historically with Symatese, a company recognized for the quality of its technological platforms to extract and transform biopolymers for multiple therapeutic indications. These reconstructed tissues have become a reference in the field of biomedical research, and a key tool for a number of industries as reliable non-animal evaluation methods for ingredient and product testing.

"Following our long-term collaboration with Symatese, we are very pleased to enter into this new phase of our scientific partnership, which supports the exploration of new horizons for research and innovation, with the objective to offer men and women around the world even more superior product performance with our beauty and skincare offering. Through this collaboration and thanks to Symatese's expertise in the therapeutic field, L'Oréal will benefit from an internationally recognized cutting-edgeknow-how in the field of biomaterials," said Barbara Lavernos, Deputy CEO in charge of

Research, Innovation and Technology, L'Oréal Group.

Jean-PaulGérardin, CEO of Symatese Group, said: "We are delighted to establish this new partnership with L'Oréal, whose extensive expertise in the field of skin physiology, clinical performance markers and alternative assessment methods perfectly matches our knowledge in the design and industrialization of biomaterials. We expect great scientific advances and innovative products from this collaboration."

About Symatese

Founded 24 years ago, Symatese Group employs 350 people. Every year, its innovative medical devices, combined with their delivery systems, are used by specialized practitioners, and make it possible to treat more than 20 Million patients worldwide per year. These products are created, developed, and manufactured within its 4 entities that operate its various technological platforms including tissue reconstruction and regeneration, inspired by nature, for various specialties, mostly surgical: plastic, reconstructive and aesthetic, cardiac and vascular, ophthalmic, orthopedic and rheumatological, dental and maxillofacial.

For more information: https://www.symatese.com

About L'Oréal

L'Oréal has devoted itself to beauty for over 100 years. With its unique international portfolio of 35 diverse and complementary brands, the Group generated sales amounting to 27.99 billion euros in 2020 and employs 85,400 people worldwide. As the world's leading beauty company, L'Oréal is present across all distribution networks: mass market, department stores, pharmacies and drugstores, hair salons, travel retail, branded retail and e-commerce.

Research and innovation with a dedicated research team of 4,000 people, are at the core of L'Oréal's strategy, working to meet beauty aspirations all over the world. L'Oréal sets out ambitious sustainable development goals across the Group for 2030 and aims to empower its ecosystem for a more inclusive and sustainable society.

More information on https://www.loreal.com/en/mediaroom

1

"This press release does not constitute an offer of sale or solicitation of an offer to purchase L'Oréal shares. If you wish to obtain more comprehensive information about L'Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers, also available in English on our website www.loreal-finance.com.

This press release may contain forecast information. While the Company believes that these statements are based on reasonable assumptions as of the date of publication of this press release, they are by nature subject to risks and uncertainties which may lead to a discrepancy between the actual figures and those indicated or suggested in these statements."

CONTACTS

Individual shareholders and market

Financial analysts and institutional

Media

L'ORÉAL

regulators

investors

Christian MUNICH

Françoise LAUVIN

Noëlle CAMILLERI

Switchboard

+33 (0)1 47 56 72 06

+33 (0)1 47 56 86 82

+33 (0)6 79 92 99 39

+33 (0)1 47 56 70 00

Christian.munich2@loreal.com

Francoise.lauvin@loreal.com

Noelle.camilleri@loreal.com

Christine BURKE

+33 (0)6 75 54 38 15

Christine.burke@loreal.com

CONTACTS

Business Development

Médias

SYMATESE

Laurent Brones

Patricia Bénitah

l.brones@symatese.com

+33 (0)6 29 44 83 09

pbcom@pbcommunication.fr

For further information, please contact your bank, stockbroker of financial institution (I.S.I.N. code: FR000012031) and consult your usual newspapers or magazines or the Internet site for shareholders

and investors, www.loreal-finance.com,the L'Oréal Finance app or call the toll-free number from France: 0 800 66 66 66. 0 800 66 66 66

Follow us on Twitter @loreal

www.loreal.com

www.symatese.com

2

Disclaimer

L'Oréal SA published this content on 28 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 October 2021 17:32:09 UTC.


© Publicnow 2021
All news about L'ORÉAL
01/18LOREAL : UBS reiterates its Buy rating
MD
01/18LOREAL : Gets a Buy rating from JP Morgan
MD
01/17LOREAL : JP Morgan keeps its Buy rating
MD
01/17MARKETSCREENER’S WORLD PRESS REVIEW : January 17, 2022
01/16Loop Industries, Inc.
AQ
01/16Plastics and recycling company Loop Industries to create 180 jobs at new French site
RE
01/15GSK rejects 50-billion-pound Unilever offer for consumer assets
RE
01/04L'Oreal unveils latest beauty tech innovations ahead of CES 2022
AQ
01/03L'ORÉAL GROUPE : L'Oréal unveils latest beauty tech innovations ahead of ces 2022
PU
01/03L'OREAL : L'Oréal unveils latest Beauty Tech innovations ahead of CES 2022
PU
More news
Analyst Recommendations on L'ORÉAL
More recommendations
Financials
Sales 2021 31 852 M 36 115 M 36 115 M
Net income 2021 4 500 M 5 103 M 5 103 M
Net cash 2021 6 181 M 7 008 M 7 008 M
P/E ratio 2021 46,3x
Yield 2021 1,21%
Capitalization 210 B 238 B 238 B
EV / Sales 2021 6,39x
EV / Sales 2022 5,78x
Nbr of Employees 85 392
Free-Float -
Chart L'ORÉAL
Duration : Period :
L'Oréal Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends L'ORÉAL
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 376,00 €
Average target price 400,53 €
Spread / Average Target 6,52%
EPS Revisions
Managers and Directors
Nicolas Hieronimus Chief Executive Officer & Director
Christophe Babule Chief Financial Officer
Jean-Paul Agon Deputy Chief Executive Officer
Barbara Lavernos Deputy CEO-Research, Innovation & Technology
Antoine Vanlaeys Operations Director-Asia Pacific Zone
Sector and Competitors
1st jan.Capi. (M$)
L'ORÉAL-9.82%237 603
KAO CORPORATION-5.03%23 640
SHISEIDO COMPANY, LIMITED-9.39%20 263
DCC PLC7.14%8 682
AMOREPACIFIC CORPORATION-10.18%7 948
COTY INC.-14.95%7 244